Overexpression of Interleukin-13 in a Murine T-Cell Lymphoma: A Possible Factor of DL-Induced Immunosuppression and Tumor Progression

REFERENCES

• Parajuli P., Singh S. M., Kumar A., Sodhi A. Alterations in the tumoricidal functions of murine tumor-associated macrophages during progressive growth of a tumor in vivo. Cancer J 1997; 10: 222–227
   Web of Science ®Google Scholar
• Pawlec G., Zeuthen J., Kiessling R. Escape from host anti-tumor immunity. Crit Rev Oncog 1997; 8: 111–141
   PubMed Web of Science ®Google Scholar
• Chouaib S., Asselin Paturel G., Mami Chouaib F., Caignard A., Blay J. Y. The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunol Today 1997; 18: 493–497
   PubMedGoogle Scholar
• Sulitzeanu D. Immunosuppressive factors in human cancer. Adv Cancer Res 1993; 60: 247–267
   PubMed Web of Science ®Google Scholar
• Oppenheim J., Fujiwara H. The role of cytokines in cancer. Cytokine Growth Factor Rev 1996; 7: 279–288
   PubMedGoogle Scholar
• Morisaki T., Katano M., Ikubo A., et al. Immunosuppressive cytokines (IL-10, TGF-β)genes expression in human gastric carcinoma tissue. J Surg Oncol 1996; 63: 234–239
   PubMed Web of Science ®Google Scholar
• Spellman J. E., Gollnick S. O., Zhang P. J., Tomasi T. B. Cytokine production by human soft tissue sarcomas: implications for immunosuppression within the tumor bed. Surg Oncol 1996; 5: 237–244
   PubMed Web of Science ®Google Scholar
• Venetsanakos E., Beckman I., Bradley J., Skinner J. M. High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours. Br J Cancer 1997; 75: 1826–1830
   PubMed Web of Science ®Google Scholar
• Romagnani S. Lymphokine production by human T-cells in disease states. Annu Rev Immunol 1994; 12: 227–257
   PubMed Web of Science ®Google Scholar
• Terabe M., Matsui S., Noben-Trauth N., et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4-STAT-6 pathway. Nat Immunol 2000; 1: 515–520
   PubMed Web of Science ®Google Scholar
• Terabe M., Matsui S., Park J. M., et al. Transforming growth factor-β production and myeloid cells are an effector mechanism through which CD1d-restricted T-cells block cytotoxic T-lymphocyte–mediated tumor immune surveillance: abrogation prevent tumor reoccurrence. J Exp Med 2003; 198: 1741–1752
   PubMed Web of Science ®Google Scholar
• Lai Y. H., Heslam J. M., Poppema S., Elliott J. F., Mosmann T. R. Continuous administration of IL-13 to mice induces extramedullary hemopoiesis and monocytosis. J Immunol 1996; 156: 3166–3173
   PubMed Web of Science ®Google Scholar
• Zurawski S. M., Vega F. Jr, Hugghe B., Zurawski G. Receptors for IL-13 and IL-4 are complex and share a novel component that functions in signal transduction. EMBO J 1993; 12: 2663–2670
   PubMed Web of Science ®Google Scholar
• Punnonen J., Aversa G., Cocks B. G., et al. Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B-cell. Proc Natl Acad Sci USA 1993; 90: 3730–3734
   PubMed Web of Science ®Google Scholar
• Doherty M., Kastelein K., Menon S., Andrade S., Coffman R. L. Modulation of murine macrophages function by IL-13. J Immunol 1993; 151: 7151–7160
   PubMed Web of Science ®Google Scholar
• de Waal Malefyt R., Figdor C., Hujibens R., et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. J Immunol 1993; 151: 6370–6381
   PubMed Web of Science ®Google Scholar
• Bogdan C., Thuring H., Dlaska M., Rollinghoff M., Weiss G. Mechanism of suppression of macrophage nitric oxide release by IL-13: influence of the macrophages population. J Immunol 1997; 159: 4506–4513
   PubMed Web of Science ®Google Scholar
• Doyle A. G., Herbein G., Montaner L. J., et al. Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma. Eur J Immunol 1994; 24: 1441–1445
   PubMed Web of Science ®Google Scholar
• Cocks B. G., de Waal Malefyt R., Galizzi J. P., de Vries J. E., Aversa G. Interleukin-13 induces proliferation and differentiation of human B-cells activated by the CD40 ligand. Int Immunol 1993; 5: 657–663
   PubMed Web of Science ®Google Scholar
• McKenzie A. N. Regulation of T helper type 2 cell immunity by interleukin-4 and interleukin-13. Pharmacol Ther 2000; 88: 143–151
   PubMed Web of Science ®Google Scholar
• Kapp U., Yeh W. C., Patterson B., et al. IL-13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J Exp Med 1999; 189: 1939–1946
   PubMed Web of Science ®Google Scholar
• Skinnider B. F., Elia A. J., Gascoyne R. D., et al. Interleukin 13 and IL-13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2001; 97: 250–255
   PubMed Web of Science ®Google Scholar
• Singh M. P., Rai A. K., Singh S. M. Gender dimorphism in the progressive in vivo growth of a T-lymphoma: involvement of cytokines and gonadal hormones. J Repro Immunol 2005; 65: 17–32
   PubMed Web of Science ®Google Scholar
• Muchamuel T., Menon S., Piscane P., Howard M. C., Cockayne D. A. IL-13 protects mice from lipopolysaccharide induced lethal endotoxemia: correlation with down-modulation of TNF-α, IFN-γ and IL-12 production. J Immunol 1997; 158: 2898–2903
   PubMed Web of Science ®Google Scholar
• Di Santo E., Meazza C., Seroni M., et al. IL-13 inhibits TNF production but potentiates that of IL-6 in vivo and ex vivo in mice. J Immunol 1997; 159: 379–382
   PubMed Web of Science ®Google Scholar
• Wojciechowska Lacka A., Matecka Nowak M., Adamiak E., Lacki J. K., Cerkaska-Gluszak B. Serum levels of interleukin-10 and interleukin-6 in patients with lung cancer. Neoplasma 1996; 43: 155–158
   PubMed Web of Science ®Google Scholar
• Fortis C., Foppoli M., Gianotti L., et al. Increased interleukin-10 serum levels in patients with solid tumors. Cancer Lett 1996; 104: 1–5
   PubMed Web of Science ®Google Scholar
• Finkelman F. D., Wynn T. A., Donaldson D. D., Urban J. F. The role of IL-13 in helminth-induced inflammation and protective immunity against nematode infections. Curr Opin Immunol 1999; 11: 420–426
   Google Scholar
• Peritt D., Robertson S., Gri G., Showe L., Aste-Amezaga M., Trinchieri G. Differentiation of human NK-cells into NK1 and NK2 subsets. J Immunol 1998; 161: 5821–5824
   PubMed Web of Science ®Google Scholar
• Burd P. R., Thompson W. C., Max E. E., Mills F. C. Activated mast cells produce interleukin 13. J Exp Med 1995; 181: 1373–1380
   PubMedGoogle Scholar
• McKenzie A. N.J., Culpepper J. A., de waal Malefyt R., et al. Interleukin-13, a T-cell derived cytokine that regulates human monocytes and B-cell function. Proc Natl Acad Sci USA 1993; 90: 3735–3739
   PubMed Web of Science ®Google Scholar
• Deepak P., Sanjay K., Acharya A. IL-13 Rα 2-mediated interleukin-13 neutralization represses in vivo progressive growth of a T-cell lymphoma. J Exp Clin Cancer Res 2007; 26: 515–520
   PubMedGoogle Scholar
• Pollard J. W. Tumor-associated macrophages promote tumor progression and metastasis. Nat Rev Cancer 2004; 4: 71–78
   PubMed Web of Science ®Google Scholar
• Mantovani A., Allavena P., Sica A. Tumor-associated macrophages as a prototypic type II polarized phagocyte population: role in tumor progression. Eur J Cancer 2004; 40: 1660–1667
   PubMed Web of Science ®Google Scholar